Expression of vascular endothelial growth factor is related to microvessel injury of renal interstitium in children with Henoch Sch nlein purpura nephritis
ZENG Xue-Qi, XU Zi-Chuan, DANG Xi-Qiang, HE Xiao-Jie, YI Zhu-Wen.
Pediatric Nephropathy Institute, Second Xiangya Hospital, Central South University/Clinical Center of Pediatric Renal Disease in Hunan Province, Changsha 410011 China. Email: happydang@tom.com
Abstract：OBJECTIVE: To investigate the relationship between vascular endothelial growth factor (VEGF) expression and microvessel injury of renal interstitium in children with Henoch-Sch?nlein purpura nephritis (HSPN). METHODS: Thirty-two children with HSPN and who had not received glucocorticoid or immunodepressants treatment before hospitalization were enrolled. Five children undergoing nephrectomy due to renal trauma were used as the control group. Renal samples were stained by hematoxylin and eosin and renal pathological changes were evaluated semiquantitatively. CD34 and VEGF expression was detected by immunohistochemistry. CD34 was used as the marker for endothelial cells of renal microvessels. The microvessel density (MVD) was calculated by CD34 immunostaining. RESULTS: Compared with the control and the renal pathological grade II HSPN groups, MVD in the grade III and above HSPN groups decreased significantly, with an obvious reduction in MVD with the increased renal pathological grade (P<0.05). The renal microvessel score in the grades IIIa, IIIb, IV, and V HSPN groups decreased obviously compared with that in the control group. The renal microvessel score decreased with the increased renal pathological grade (P<0.05). VEGF expression in the grade II HSPN group was higher (P<0.05), while that in the grades IV and V HSPN group was lower than that in the control group (P<0.05). VEGF expression in the HSPN group showed a significant reduction with the increased renal pathological grade (P<0.05). There was a positive correlation between VEGF expression and MVD in renal tissue in the HSPN group (r=0.935, P<0.01). CONCLUSIONS: The decreased expression of VEGF may be responsible for the renal pathological damage and microvessel injury in HSPN.［Chin J Contemp Pediatr, 2009, 11 (9):717-721］
ZENG Xue-Qi,XU Zi-Chuan,DANG Xi-Qiang et al. Expression of vascular endothelial growth factor is related to microvessel injury of renal interstitium in children with Henoch Sch nlein purpura nephritis[J]. CJCP, 2009, 11(9): 717-721.
［2］Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy［J］.Am Soc Nephrol, 2002, 13(7):1795-1805.
［3］Kang DH, Kangellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, et al. Role of The microvascular endothelium in progressive renal disease［J］. J Am Soc Nephrol, 2002, 13(3):806-816.
［4］Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease［J］. Am J Kidney Dis, 2001, 37(3):601-611
［5］Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats［J］. J Am Soc Nephrol, 2000, 11(1):47-56.
［6］Ferrara N, Gerber HO, LeCouter J. The biology of VEGF and its receptors［J］.Nat Med, 2003, 9(6):669-676.
［7］Gera N, Tzafra C, Stela G, Zoya P. Vascular endothelial growth factor (VEGF) and its receptors［J］. FASEB J, 1999, 13(1):9-22.
［8］Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor(VEGF) in renal pathophysiology［J］. Kidney Int, 2004, 65(6):2003-2017.
［13］Ohashi R, Shimizu A, Masuda Y, Hiroshi K, Masamichi I, Yuichi S, et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy［J］. J Am Soc Nephrol, 2002, 13(7):1795-1805.
［14］Bailey E, Bottomley MJ, Westwell S, Pringle JH, Furness PN, Feehally J, et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridization［J］.J Clin Pathol, 1999, 52(10):735-738.
［15］Topaloglu R, Sungur A, Baskin E, Besbab N, Saatci U, Bakkaloglu A, et al. Vascular endothelial growth factor in Henoch-Schonlein purpura［J］. J Rheumatol, 2001, 28(10):2269-2273.
［17］Simon M, Rockl W, Horning C, Grone EF, Theis H, Weich HA, et al. Receptors of vascular endothelial growth factor/vascular permeability factor(VEGF/VPF) in fetal and adult human kidney:localization and VEGF binding site［J］. Am Soc Nephrol, 1998, 9(6):1032-1044.
［18］Kitamura H, Shimizu A, Masuda Y, Kitamura H,Shimizu A, Masuda Y, et al. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model［J］.Exp Nephrol, 1998, 6(4):328-336.
［19］Shimizu A, Kitamura H, Masuda Y, Ishizaki M, Sugisaki Y, Yamanaka N. Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis［J］. Am J Pathol, 1997, 151(5):1231-1239.
［22］Kang DH, Hughes J, Mazzali M, George FS, Richard JJ. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function［J］.J Am Soc Nephrol, 2001, 12(7):1448-1457.
